Daniel K. Spiegelman, EVP, Chief Financial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 24,786 shares at $89.35 ($2.2M) on 2016-05-31, disclosed to the SEC on 2016-06-02.
Open-market sale of $2.2M BMRN by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.35 | 3,945 | $352K | 15.8% |
| 2 | $89.35 | 3,945 | $352K | 15.8% |
| 3 | $90.00 | 16,896 | $1.5M | 68.3% |
| Total | $89.79 avg | 24,786 | $2.2M | 100% |
| Filing → |
| MYGN | SELL | 2022-06-06 | $124K | — | Filing → |
| MYGN | SELL | 2021-06-17 | $192K | — | Filing → |
| MYGN | SELL | 2021-06-01 | $414K | — | Filing → |